Dynavax's market cap is currently $1.28B. The company's EPS TTM is $0.21; its P/E ratio is ―; Dynavax is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
